Otros idiomas KALA BIO, Inc. Deutsche Boerse AG

Acciones

27F0

US4831192020

Tiempo real estimado Tradegate Otros sitios de cotización 12:10:29 03/07/2024			Varia. Cinco días.	Varia. 1 de enero.
6,248 ^EUR	-1,06 %		+42,86 %	-7,04 %

27/06	Principales ganancias del mediodía	MT
27/06	Actualización del sector: Los valores del sector sanitario, mixtos antes de la sesión del jueves	MT

Otros idiomas

Desbloquee todas las noticias sobre todas las empresas: ¡No vuelvas a perderse una oportunidad de inversión rentable!

Inscripción 100% Gratuita

KALA BIO, Inc. announced that it has received $12.499192 million in funding from Baker Bros. Advisors LP, ADAR1 Capital Management, LLC, SR One Capital Management, LP	28/06
Top Midday Gainers	27/06
Sector Update: Health Care Stocks Mixed Premarket Thursday	27/06
Kala Bio to Raise $12.5 Million in Private Placement; Shares Jump	27/06
KALA BIO Announces $12,500,000 Private Placement	27/06
KALA BIO, Inc. announced that it expects to receive $12.499192 million in funding from Baker Bros. Advisors LP, ADAR1 Capital Management, LLC, SR One Capital Management, LP	26/06
KALA BIO : Corporate Overview - June 2024	05/06
KALA BIO to Present at Jefferies Global Healthcare Conference	29/05
KALA BIO, Inc. Reports Earnings Results for the First Quarter Ended March 31, 2024	14/05
KALA BIO Reports First Quarter 2024 Financial Results and Provides Corporate Update	14/05
KALA BIO Reports Fourth Quarter and Full Year 2023 Financial Results and Provides Corporate Update	01/04
KALA BIO, Inc. Reports Earnings Results for the Full Year Ended December 31, 2023	29/03
KALA BIO, Inc. Reports Earnings Results for the Fourth Quarter Ended December 31, 2023	29/03
KALA BIO Reports Fourth Quarter and Full Year 2023 Financial Results and Provides Corporate Update	29/03
KALA BIO, Inc. announced that it expects to receive $8.599799 million in funding from Baker Bros. Advisors LP	25/03
North American Morning Briefing : Stocks Struggle After New Records	22/03
North American Morning Briefing : Inflation -2-	15/03
KALA BIO to Present at TD Cowen 44th Annual Healthcare Conference	26/02
KALA BIO to Present at Oppenheimer 34th Annual Healthcare Life Sciences Conference	06/02
KALA BIO Reports Inducement Grants Under Nasdaq Listing Rule 5635(c)(4)	19/01

No hay resultados para esta búsqueda

Todas Recomendaciones analistas Eventos destacados Insiders Transcripts Comunicados Publs. oficiales Otros idiomas Ideas de trading Artículos de MarketScreener Estrategias MarketScreener

Otros idiomas KALA BIO, Inc. Deutsche Boerse AG

Acciones

27F0

US4831192020

Otros idiomas

Filtros